Petros Pharmaceuticals, Inc. (PTPI) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
11/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LosePTPI / S&P -16.67% / 15.20% |
LosePTPI / S&P PTPI unavailable / 15.00% |
LosePTPI / S&P -100.08% / 50.40% |
| 2026-Q10/3 |
LosePTPI / S&P -25.00% / -4.33% |
LosePTPI / S&P PTPI unavailable / 11.30% |
LosePTPI / S&P -98.17% / 27.70% |
| 2025-Q40/3 |
LosePTPI / S&P -66.67% / 2.65% |
LosePTPI / S&P PTPI unavailable / 9.00% |
LosePTPI / S&P -87.28% / 13.40% |
| 2025-Q30/3 |
LosePTPI / S&P -29.41% / 8.12% |
LosePTPI / S&P PTPI unavailable / 4.61% |
LosePTPI / S&P -67.29% / 13.45% |
| 2025-Q20/3 |
LosePTPI / S&P -98.03% / 10.94% |
LosePTPI / S&P PTPI unavailable / 4.83% |
LosePTPI / S&P -29.49% / 10.63% |
| 2025-Q10/3 |
LosePTPI / S&P -82.49% / -4.27% |
LosePTPI / S&P PTPI unavailable / 4.98% |
LosePTPI / S&P -0.81% / 10.57% |
| 2024-Q42/3 |
WinPTPI / S&P 10.36% / 2.41% |
LosePTPI / S&P -12.20% / 5.25% |
WinPTPI / S&P 1168.40% / 6.15% |
| 2024-Q31/3 |
LosePTPI / S&P -22.05% / 5.89% |
LosePTPI / S&P -42.41% / 5.89% |
WinPTPI / S&P 934.27% / 6.11% |
| 2024-Q21/3 |
LosePTPI / S&P -69.05% / 4.28% |
LosePTPI / S&P PTPI unavailable / 5.38% |
WinPTPI / S&P 428.45% / 5.12% |
| 2024-Q11/3 |
LosePTPI / S&P 4.96% / 10.56% |
LosePTPI / S&P PTPI unavailable / 5.71% |
WinPTPI / S&P 366.47% / 5.59% |
| 2023-Q40/3 |
LosePTPI / S&P -18.50% / 11.69% |
LosePTPI / S&P PTPI unavailable / 6.81% |
LosePTPI / S&P -34.61% / 7.78% |
| 2023-Q30/3 |
LosePTPI / S&P -14.78% / -3.27% |
LosePTPI / S&P PTPI unavailable / 7.52% |
LosePTPI / S&P -57.40% / -5.03% |
| 2023-Q22/3 |
WinPTPI / S&P 45.52% / 8.74% |
LosePTPI / S&P PTPI unavailable / 9.50% |
WinPTPI / S&P 13.76% / -8.57% |
| 2023-Q11/3 |
LosePTPI / S&P -40.13% / 7.50% |
LosePTPI / S&P PTPI unavailable / 10.77% |
WinPTPI / S&P 18.75% / -15.69% |
| 2022-Q41/3 |
LosePTPI / S&P -54.31% / 7.56% |
LosePTPI / S&P PTPI unavailable / 11.88% |
WinPTPI / S&P 17.33% / -17.99% |
| 2022-Q30/3 |
LosePTPI / S&P -39.29% / -4.88% |
LosePTPI / S&P PTPI unavailable / 13.47% |
LosePTPI / S&P -3395.83% / -1.41% |
| 2022-Q21/3 |
LosePTPI / S&P -46.15% / -16.10% |
LosePTPI / S&P -38.66% / 13.71% |
WinPTPI / S&P 2900.00% / 11.04% |
| 2022-Q10/3 |
LosePTPI / S&P -53.15% / -4.60% |
LosePTPI / S&P -47.64% / 15.97% |
LosePTPI / S&P PTPI unavailable / 42.23% |
| 2021-Q41/3 |
WinPTPI / S&P 66.50% / 11.03% |
LosePTPI / S&P -18.29% / 15.00% |
LosePTPI / S&P PTPI unavailable / 96.40% |
| 2021-Q30/3 |
LosePTPI / S&P -36.10% / 0.58% |
LosePTPI / S&P PTPI unavailable / 10.77% |
LosePTPI / S&P PTPI unavailable / 69.42% |
| 2021-Q20/3 |
LosePTPI / S&P -16.09% / 8.55% |
LosePTPI / S&P PTPI unavailable / 6.58% |
LosePTPI / S&P PTPI unavailable / 51.81% |
| 2021-Q10/3 |
LosePTPI / S&P -15.23% / 6.17% |
LosePTPI / S&P PTPI unavailable / -1.06% |
LosePTPI / S&P PTPI unavailable / 7.39% |
| 2020-Q40/3 |
LosePTPI / S&P PTPI unavailable / 12.15% |
LosePTPI / S&P PTPI unavailable / -3.72% |
LosePTPI / S&P PTPI unavailable / -33.42% |
| 2020-Q30/3 |
LosePTPI / S&P PTPI unavailable / 8.93% |
LosePTPI / S&P PTPI unavailable / -2.04% |
LosePTPI / S&P PTPI unavailable / -27.10% |
| 2020-Q20/3 |
LosePTPI / S&P PTPI unavailable / 20.54% |
LosePTPI / S&P PTPI unavailable / -0.46% |
LosePTPI / S&P PTPI unavailable / -27.11% |
| 2020-Q10/3 |
LosePTPI / S&P PTPI unavailable / -19.60% |
LosePTPI / S&P PTPI unavailable / 3.47% |
LosePTPI / S&P PTPI unavailable / -14.75% |
| 2019-Q40/3 |
LosePTPI / S&P PTPI unavailable / 9.07% |
LosePTPI / S&P PTPI unavailable / 5.36% |
LosePTPI / S&P PTPI unavailable / 2.99% |
| 2019-Q30/3 |
LosePTPI / S&P PTPI unavailable / 1.70% |
LosePTPI / S&P PTPI unavailable / 5.02% |
LosePTPI / S&P PTPI unavailable / 0.21% |
| 2019-Q20/3 |
LosePTPI / S&P PTPI unavailable / 4.30% |
LosePTPI / S&P PTPI unavailable / 6.64% |
LosePTPI / S&P PTPI unavailable / 8.65% |
| 2019-Q10/3 |
LosePTPI / S&P PTPI unavailable / 13.65% |
LosePTPI / S&P PTPI unavailable / 8.12% |
LosePTPI / S&P PTPI unavailable / 14.29% |
| 2018-Q40/3 |
LosePTPI / S&P PTPI unavailable / -13.52% |
LosePTPI / S&P PTPI unavailable / 9.05% |
LosePTPI / S&P PTPI unavailable / 18.23% |
| 2018-Q30/3 |
LosePTPI / S&P PTPI unavailable / 7.71% |
LosePTPI / S&P PTPI unavailable / 10.21% |
LosePTPI / S&P PTPI unavailable / 19.06% |
| 2018-Q20/3 |
LosePTPI / S&P PTPI unavailable / 3.43% |
LosePTPI / S&P PTPI unavailable / 9.03% |
LosePTPI / S&P PTPI unavailable / 14.46% |
| 2018-Q10/3 |
LosePTPI / S&P PTPI unavailable / -0.76% |
LosePTPI / S&P PTPI unavailable / 7.68% |
LosePTPI / S&P PTPI unavailable / 12.46% |
| 2017-Q40/3 |
LosePTPI / S&P PTPI unavailable / 6.64% |
LosePTPI / S&P PTPI unavailable / 7.03% |
LosePTPI / S&P PTPI unavailable / 13.82% |
| 2017-Q30/3 |
LosePTPI / S&P PTPI unavailable / 4.48% |
LosePTPI / S&P PTPI unavailable / 5.68% |
LosePTPI / S&P PTPI unavailable / 17.57% |
| 2017-Q20/3 |
LosePTPI / S&P PTPI unavailable / 3.09% |
LosePTPI / S&P PTPI unavailable / 4.83% |
LosePTPI / S&P PTPI unavailable / 17.74% |
| 2017-Q10/3 |
LosePTPI / S&P PTPI unavailable / 6.07% |
LosePTPI / S&P PTPI unavailable / 3.67% |
LosePTPI / S&P PTPI unavailable / 13.32% |
| 2016-Q40/3 |
LosePTPI / S&P PTPI unavailable / 3.82% |
LosePTPI / S&P PTPI unavailable / 2.09% |
LosePTPI / S&P PTPI unavailable / 7.05% |
| 2016-Q30/3 |
LosePTPI / S&P PTPI unavailable / 3.85% |
LosePTPI / S&P PTPI unavailable / 0.20% |
LosePTPI / S&P PTPI unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PTPI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -86.67% | 20.78% |
| Annualized return | -86.67% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PTPI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 83.14% |
| Annualized return | -90.76% | 12.86% |
10Y · 2020-12-02 to 2026-08-27
| Metric | PTPI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -71.14% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |